Bioterror Animal Models Need Development Incentives, Chimerix CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Chimerix CEO George Painter tells Senate Health subcommittee that limitations on current animal modeling are a significant barrier to the registration of biodefense products using the animal rule.